Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) FCF Margin (2016 - 2018)

Historic FCF Margin for ENDRA Life Sciences (NDRA) over the last 3 years, with Q1 2018 value amounting to 39713.15%.

  • ENDRA Life Sciences' FCF Margin changed N/A to 39713.15% in Q1 2018 from the same period last year, while for Dec 2018 it was 126376.43%, marking a year-over-year decrease of 1254376700.0%. This contributed to the annual value of 6836.54% for FY2024, which is 47555400.0% down from last year.
  • Latest data reveals that ENDRA Life Sciences reported FCF Margin of 39713.15% as of Q1 2018.
  • In the past 5 years, ENDRA Life Sciences' FCF Margin registered a high of 304.81% during Q2 2016, and its lowest value of 39713.15% during Q1 2018.
  • In the last 3 years, ENDRA Life Sciences' FCF Margin had a median value of 1083.98% in 2017 and averaged 10293.96%.
  • Over the last 5 years, ENDRA Life Sciences' FCF Margin had its largest YoY gain of -22823200bps in 2017, and its largest YoY loss of -199755900bps in 2017.
  • ENDRA Life Sciences' FCF Margin (Quarter) stood at 105.93% in 2016, then crashed by -18857bps to 20081.52% in 2017, then crashed by -98bps to 39713.15% in 2018.
  • Its FCF Margin was 39713.15% in Q1 2018, compared to 20081.52% in Q4 2017 and 190.46% in Q3 2017.